In vivo relevance of citrullinated proteins and the challenges in their detection

Proteomics

Volumn 12, Issue 6, 2012, Pages 752-760

  De Ceuleneer, Marlies ^a   Van Steendam, Katleen ^a   Dhaenens, Maarten ^a   Deforce, Dieter ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

2D PAGE; Citrullination; Mass spectrometry; Posttranslational modification; Specific labeling; Technology

Indexed keywords

ALPHA ENOLASE; CITRULLINATED PROTEIN; COLLAGEN TYPE 2; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; HISTONE; LEUKOCYTE ANTIGEN; MYELIN BASIC PROTEIN; PEPTIDES AND PROTEINS; PROTEIN ARGININE DEIMINASE; UNCLASSIFIED DRUG; VIMENTIN;

ALZHEIMER DISEASE; APOPTOSIS; CELL STRUCTURE; CITRULLINATION; DNA DEGRADATION; GENETIC TRANSCRIPTION; GLAUCOMA; HUMAN; IMMUNODETECTION; IN VIVO STUDY; MASS SPECTROMETRY; MULTIPLE SCLEROSIS; NEOPLASM; NUCLEOSOME; OPEN ANGLE GLAUCOMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MODIFICATION; REVIEW; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CITRULLINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; MASS SPECTROMETRY; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS;

EID: 84860349570     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100478     Document Type: Review

References (56)

1. Gyorgy, B., Toth, E., Tarcsa, E., Falus, A. et al., Citrullination: a posttranslational modification in health and disease. Int. J. Biochem. Cell Biol. 2006, 38, 1662-1677.
2. Orgovan, G., Noszal, B., The complete microspeciation of arginine and citrulline. J. Pharm. Biomed. Anal. 2011, 54, 965-971.
3. Inagaki, M., Takahara, H., Nishi, Y., Sugawara, K. et al., Ca2+-dependent deimination-induced disassembly of intermediate filaments involves specific modification of the amino-terminal head domain. J. Biol. Chem. 1989, 264, 18119-18127.
4. Cuthbert, G. L., Daujat, S., Snowden, A. W., Erdjument-Bromage, H. et al., Histone deimination antagonizes arginine methylation. Cell 2004, 118, 545-553.
5. Ying, S., Dong, S., Kawada, A., Kojima, T. et al., Transcriptional regulation of peptidylarginine deiminase expression in human keratinocytes. J. Dermatol. Sci. 2009, 53, 2-9.
6. Liu, G., Liao, Y., Chang, W., Liu, C. et al., Overexpression of peptidylarginine deiminase IV features in apoptosis of haematopoietic cells. Apoptosis 2006, 11, 183-196.
7. Wang, Y., Li, M., Stadler, S., Correll, S. et al., Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J. Cell Biol. 2009, 184, 205-213.
8. Dieker, J., Muller, S., Epigenetic histone code and autoimmunity. Clin. Rev. Allergy Immunol. 2010, 39, 78-84.
9. Chavanas, S., Mechin, M., Nachat, R., Adoue, V. et al., Peptidylarginine deiminases and deimination in biology and pathology: relevance to skin homeostasis. J. Dermatol. Sci. 2006, 44, 63-72.
10. Chang, X., Fang, K., PADI4 and tumourigenesis. Cancer Cell Int. 2010, 10, 7.
11. Gallet, X., Charloteaux, B., Thomas, A., Brasseur, R., A fast method to predict protein interaction sites from sequences. J. Mol. Biol. 2000, 302, 917-926.
12. Andrade, F., Darrah, E., Gucek, M., Cole, R. N. et al., Autocitrullination of human peptidylarginine deiminase 4 regulates protein citrullination during cell activation. Arthritis Rheum. 2010, 62, 1630-1640.
13. Esposito, G., Vitale, A. M., Leijten, F. P., Strik, A. M. et al., Peptidylarginine deiminase (PAD) 6 is essential for oocyte cytoskeletal sheet formation and female fertility. Mol. Cell Endocrinol. 2007, 273, 25-31.
14. Dong, S., Zhang, Z., Takahara, H., Estrogen-enhanced peptidylarginine deiminase type IV gene (PADI4) expression in MCF-7 cells is mediated by estrogen receptor-alpha-promoted transfactors activator protein-1, nuclear factor-Y, and Sp1. Mol. Endocrinol. 2007, 21, 1617-1629.
15. Ishigami, A., Ohsawa, T., Hiratsuka, M., Taguchi, H. et al., Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease. J. Neurosci. Res. 2005, 80, 120-128.
16. Bhattacharya, S. K., Crabb, J. S., Bonilha, V. L., Gu, X. et al., Proteomics implicates peptidyl arginine deiminase 2 and optic nerve citrullination in glaucoma pathogenesis. Invest. Ophthalmol. Vis. Sci. 2006, 47, 2508-2514.
17. Makrygiannakis, D., af Klint, E., Lundberg, I. E., Lofberg, R. et al., Citrullination is an inflammation-dependent process. Ann. Rheum. Dis. 2006, 65, 1219-1222.
18. Chapuy-Regaud, S., Sebbag, M., Baeten, D., Clavel, C. et al., Fibrin deimination in synovial tissue is not specific for rheumatoid arthritis but commonly occurs during synovitides. J. Immunol. 2005, 174, 5057-5064.
19. Chang, X., Han, J., Pang, L., Zhao, Y. et al., Increased PADI4 expression in blood and tissues of patients with malignant tumors. BMC Cancer 2009, 9, 40.
20. Li, P., Yao, H., Zhang, Z., Li, M. et al., Regulation of p53 target gene expression by peptidylarginine deiminase 4. Mol. Cell Biol. 2008, 28, 4745-4758.
21. Lange, S., Gogel, S., Leung, K. Y., Vernay, B. et al., Protein deiminases: new players in the developmentally regulated loss of neural regenerative ability. Dev. Biol. 355, 205-214.
22. Moscarello, M., Mastronardi, F., Wood, D., The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis. Neurochem. Res. 2007, 32, 251-256.
23. Carrillo-Vico, A., Leech, M., Anderton, S., Contribution of myelin autoantigen citrullination to T cell autoaggression in the central nervous system. J. Immunol. 2010, 184, 2839-2846.
24. Van Steendam, K., Tilleman, K., Deforce, D., The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis. Rheumatology 2011, 50, 830-837.
25. Nielen, M. M., van Schaardenburg, D., Reesink, H. W., van de Stadt, R. J. et al., Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004, 50, 380-386.
26. Klareskog, L., Ronnelid, J., Lundberg, K., Padyukov, L. et al., Immunity to citrullinated proteins in rheumatoid arthritis. Annu. Rev. Immunol. 2008, 26, 651-675.
27. Masson-Bessiere, C., Sebbag, M., Girbal-Neuhauser, E., Nogueira, L. et al., The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J. Immunol. 2001, 166, 4177-4184.
28. Rodriguez-Mahou, M., Lopez-Longo, F. J., Sanchez-Ramon, S., Estecha, A. et al., Association of anti-cyclic citrullinated peptide and anti-Sa/citrullinated vimentin autoantibodies in rheumatoid arthritis. Arthritis Rheum. 2006, 55, 657-661.
29. Kinloch, A., Tatzer, V., Wait, R., Peston, D. et al., Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res. Ther. 2005, 7, R1421-R1429.
30. Tabushi, Y., Nakanishi, T., Takeuchi, T., Nakajima, M. et al., Detection of citrullinated proteins in synovial fluids derived from patients with rheumatoid arthritis by proteomics-based analysis. Ann. Clin. Biochem. 2008, 45, 413-417.
31. Kinloch, A., Lundberg, K., Wait, R., Wegner, N. et al., Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis. Arthritis Rheum. 2008, 58, 2287-2295.
32. Tilleman, K., Van Steendam, K., Cantaert, T., De Keyser, F. et al., Synovial detection and autoantibody reactivity of processed citrullinated isoforms of vimentin in inflammatory arthritides. Rheumatology 2008, 47, 597-604.
33. Kidd, B., Ho, P., Sharpe, O., Zhao, X. et al., Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination. Arthritis Res. Ther. 2008, 10, R119.
34. Schellekens, G., de Jong, B., van den Hoogen, F., van de Putte, L. et al., Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J. Clin. Invest. 1998, 101, 273-281.
35. Huizinga, T., Amos, C., van der Helm-van Mil, A., Chen, W. et al., Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum. 2005, 52, 3433-3438.
36. Hill, J. A., Southwood, S., Sette, A., Jevnikar, A. M. et al., Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J. Immunol. 2003, 171, 538-541.
37. Doyle, H., Mamula, M., Post-translational protein modifications in antigen recognition and autoimmunity. Trends Immunol. 2001, 22, 443-449.
38. Allison, M., Fearon, D., Enhanced immunogenicity of aldehyde-bearing antigens: a possible link between innate and adaptive immunity. Eur. J. Immunol. 2000, 30, 2881-2887.
39. Carrasco-Marin, E., Paz-Miguel, J., Lopez-Mato, P., Alvarez-Dominguez, C. et al., Oxidation of defined antigens allows protein unfolding and increases both proteolytic processing and exposes peptide epitopes which are recognized by specific T cells. Immunology 1998, 95, 314-321.
40. Wallberg, M., Bergquist, J., Achour, A., Breij, E. et al., Malondialdehyde modification of myelin oligodendrocyte glycoprotein leads to increased immunogenicity and encephalitogenicity. Eur. J. Immunol. 2007, 37, 1986-1995.
41. Senshu, T., Sato, T., Inoue, T., Akiyama, K. et al., Detection of citrulline residues in deiminated proteins on polyvinylidene difluoride membrane. Anal. Biochem. 1992, 203, 94-100.
42. Kleinnijenhuis, A. J., Hedegaard, C., Lundvig, D., Sundbye, S. et al., Identification of multiple post-translational modifications in the porcine brain specific p25alpha. J. Neurochem. 2008, 106, 925-933.
43. Matsuo, K., Xiang, Y., Nakamura, H., Masuko, K. et al., Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach. Arthritis Res. Ther. 2006, 8, R175.
44. Holm, A., Rise, F., Sessler, N., Sollid, L. M. et al., Specific modification of peptide-bound citrulline residues. Anal. Biochem. 2006, 352, 68-76.
45. Stensland, M., Holm, A., Kiehne, A., Fleckenstein, B., Targeted analysis of protein citrullination using chemical modification and tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2009, 23, 2754-2762.
46. Tutturen, A. E., Holm, A., Jorgensen, M., Stadtmuller, P. et al., A technique for the specific enrichment of citrulline-containing peptides. Anal. Biochem. 2010, 403, 43-51.
47. De Ceuleneer, M., De Wit, V., Van Steendam, K., Van Nieuwerburgh, F. et al., Modification of citrulline residues with 2, 3-butanedione facilitates their detection by liquid chromatography/mass spectrometry. Rapid Commun. Mass Spectrom. 25, 1536-1542.
48. Kubota, K., Yoneyama-Takazawa, T., Ichikawa, K., Determination of sites citrullinated by peptidylarginine deiminase using O-18 stable isotope labeling and mass spectrometry. Rapid Commun. Mass Spectrom. 2005, 19, 683-688.
49. Hermansson, M., Artemenko, K., Ossipova, E., Eriksson, H. et al., MS analysis of rheumatoid arthritic synovial tissue identifies specific citrullination sites on fibrinogen. Proteomics Clin. Appl. 2010, 4, 511-518.
50. Yates, J., Ruse, C., Nakorchevsky, A., Proteomics by mass spectrometry: approaches, advances, and applications. Annu. Rev. Biomed. Eng. 2009, 11, 49-79.
51. Perry, R. H., Cooks, R. G., Noll, R. J., Orbitrap mass spectrometry: instrumentation, ion motion and applications. Mass Spectrom. Rev. 2008, 27, 661-699.
52. Dasari, S., Wilmarth, P. A., Rustvold, D. L., Riviere, M. A. et al., Reliable detection of deamidated peptides from lens crystallin proteins using changes in reversed-phase elution times and parent ion masses. J. Proteome Res. 2007, 6, 3819-3826.
53. Aebersold, R., Goodlett, D. R., Mass spectrometry in proteomics. Chem. Rev. 2001, 101, 269-295.
54. Ordonez, A., Martinez-Martinez, I., Corrales, F. J., Miqueo, C. et al., Effect of citrullination on the function and conformation of antithrombin. FEBS J. 2009, 276, 6763-6772.
55. Zhao, X., Okeke, N. L., Sharpe, O., Batliwalla, F. M. et al., Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis. Arthritis Res. Ther. 2008, 10, R94.
56. Hao, G., Wang, D., Gu, J., Shen, Q. et al., Neutral loss of isocyanic acid in peptide CID spectra: a novel diagnostic marker for mass spectrometric identification of protein citrullination. J. Am. Soc. Mass Spectrom. 2008, 20, 723-727.